Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant for Walking in Incomplete Spinal Cord Injury
NCT05398913Phase 2Completed
- Sponsor
- Hospital Nacional de Parapléjicos
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rimonabant in spinal cord injury (SCI), sponsored by Hospital Nacional de Parapléjicos. Started May 2021; status: completed.
02
Drugs
rimonabant
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05398913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398913.